tamibarotene has been researched along with cd 437 in 2 studies
| Studies (tamibarotene) | Trials (tamibarotene) | Recent Studies (post-2010) (tamibarotene) | Studies (cd 437) | Trials (cd 437) | Recent Studies (post-2010) (cd 437) |
|---|---|---|---|---|---|
| 198 | 10 | 105 | 134 | 0 | 26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, H; Iba, K; Ishii, S; Mori, M; Nuka, S; Sawada, N | 1 |
| Barbarroja, N; Buendía, P; Dorado, G; López-Pedrera, C; Torres, A; Velasco, F | 1 |
2 other study(ies) available for tamibarotene and cd 437
| Article | Year |
|---|---|
All-trans retinoic acid inhibits dexamethasone-induced ALP activity and mineralization in human osteoblastic cell line SV HFO.
Topics: Alkaline Phosphatase; Benzoates; Biomarkers; Calcification, Physiologic; Cell Line; Dexamethasone; Enzyme Inhibitors; Humans; Naphthalenes; Osteoblasts; Osteocalcin; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoids; Teratogens; Tetrahydronaphthalenes; Tretinoin | 1997 |
Promyelocytic leukemia retinoid signaling targets regulate apoptosis,tissue factor and thrombomodulin expression.
Topics: Apoptosis; Benzoates; Cell Differentiation; Cell Line, Tumor; Flavonoids; Gene Expression; Humans; Leukemia, Promyelocytic, Acute; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Retinoids; Tetrahydronaphthalenes; Thrombomodulin; Thromboplastin | 2004 |